[1]
J. L. M. Vasconcelos, “From Diabetes to Kidney Disease: A Systematic Review of the Nephroprotective Benefits of SGLT2 Inhibitors”, Braz. J. Implantol. Health Sci., vol. 6, no. 1, pp. 643–650, Jan. 2024.